Global Health Watch: US shutdown continues, WHO prequalifies lenacapavir, NIH recompetes AIDS networks – avac.org

The US government shutdown continues, impacting global health initiatives. The WHO has prequalified lenacapavir, a long-acting HIV medication, marking a significant advancement in HIV treatment accessibility for low- and middle-income countries. The National Institutes of Health (NIH) is recompeting its AIDS clinical trials networks, a crucial process for ensuring continued research and development of HIV/AIDS prevention and treatment strategies. These events highlight both challenges (US shutdown) and progress (lenacapavir prequalification, NIH networks) within the global health landscape.

News summary provided by Gemini AI.